Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
about
Apolipoprotein A-I and CancerThe clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updatesApolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trialProApolipoprotein A1: a serum marker of brain metastases in lung cancer patientsApolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells.Examining the significance of fingerprint-based classifiers.Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients.Subventricular zone involvement in Glioblastoma - A proteomic evaluation and clinicoradiological correlationSeromic profiling of ovarian and pancreatic cancer.Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoringProteomics in prostate cancer biomarker discovery.Prioritization of biomarker targets in human umbilical cord blood: identification of proteins in infant blood serving as validated biomarkers in adultsPotential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.Variant Ciz1 is a circulating biomarker for early-stage lung cancerApolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancerAltered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.Detection of pancreatic cancer using serum protein profiling.Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinomaSerum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer.Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study.Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.A comparative proteomic study of plasma in feline pancreatitis and pancreatic carcinoma using 2-dimensional gel electrophoresis to identify diagnostic biomarkers: A pilot study.Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis.Advances in biomarker research for pancreatic cancer.Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer.Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC studyPancreatic cancer screeningHigh level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.
P2860
Q26776188-713F65B1-AEBB-4FB3-9832-16A0D22E4210Q26865015-C7F9FD7D-4689-4853-8F21-4BCCC3005676Q28383260-1AC46F33-D521-4BCF-A7C7-CCC0C5B14F85Q30485388-5802DE95-DB97-4184-A0BF-9EB153F83C26Q33307131-99810136-D751-45D9-849F-B04D2CBFF22AQ33394036-D6D33FF9-BF01-4935-86B0-DDD9917E2CCAQ33605656-0F2A9AEB-D555-4943-8A05-B2ED51F9EB38Q33620112-D72C1BA0-DEAB-4CF8-96F0-DC00A3E15FACQ33624194-48F1AEFE-C1BD-4656-A3C9-09DDF74F96E1Q33683860-14E694F3-18D8-4495-BD16-C4B08B62A5DAQ33684168-2CE53130-92C7-4F9E-AFC4-B14518A5ACD6Q33739967-F5E7203F-49F6-4745-A12E-F367DD86AA2DQ33925676-3BD283C5-18DD-4393-B1F3-FB629A5CD198Q33990542-A042029E-DB74-4979-8004-8E362EAEDBB6Q34096086-25433354-BDF8-42BE-BD94-9CED51718871Q34248807-D8E57A6A-7F26-4B22-AD28-31A5D13E50DCQ34305848-0C8A362A-FA4C-4623-94B3-3890EB28DF20Q34306595-1EEB39F5-0102-4B35-8904-6948FBB91D2DQ34359284-2401EED3-7BB5-4D9F-A13D-936A89AB03B5Q34442495-8360A9C2-EA98-4812-AFD7-32C4556CA093Q34464452-41F5849E-5EB5-4EFD-A577-E9367FADD9FAQ34514797-BBE93319-51A2-4B72-9624-46609A346A94Q34607497-42F0071E-3035-4C32-B38E-54C3AB7B0B2BQ34644418-16CF19D5-FD7B-467A-8072-62BC41EDC671Q34950660-47945CA9-6526-4DCF-AD23-FDD8F1C5C91FQ35070494-947B9639-8E6C-4107-9FB5-53C256967156Q35152701-0034646E-8A49-48DC-8E73-186BC5DADFABQ35196711-13971024-A825-4B60-AFC6-F24A6BE961E4Q35266857-0B23D196-B127-42E3-A370-F1D9896CE0A0Q35652958-2D644C18-E3E1-4A11-A357-FA0D6FE66B3CQ35990884-28098E5C-DF45-4672-80DE-0665EB754EBAQ36126609-D2453843-A51B-4284-BEC1-E30860F29B16Q36262320-3A3E20F4-4721-4BAA-A30F-425AC2074E86Q36383987-72737CB7-9648-43FD-BBB8-0E8E8E7CEBA6Q36582422-84B28770-CAF1-4A9F-9C63-9D00907630E9Q36685565-66E50A2A-2E55-44A3-ACF8-E347540A7492Q36707857-3920FF71-AB9D-4F18-AB99-74D2E372D0C5Q36782675-EAEDCC2A-B5EB-43A4-8340-40E64ADE7540Q36896536-834E8D70-7601-48D2-8D90-1B9A5A8A8621Q37118144-B235ECD9-B08F-490D-8C93-982883B21734
P2860
Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Identification of potential ma ...... protein expression profiling.
@ast
Identification of potential ma ...... protein expression profiling.
@en
type
label
Identification of potential ma ...... protein expression profiling.
@ast
Identification of potential ma ...... protein expression profiling.
@en
prefLabel
Identification of potential ma ...... protein expression profiling.
@ast
Identification of potential ma ...... protein expression profiling.
@en
P2093
P50
P1433
P1476
Identification of potential ma ...... protein expression profiling.
@en
P2093
Klaus Felix
Michael Ehmann
Ralf Bogumil
Sonja Vorderwülbecke
P304
P356
10.1097/01.MPA.0000250128.57026.B2
P577
2007-03-01T00:00:00Z